Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

41.13USD
17 Dec 2014
Price Change (% chg)

$0.28 (+0.69%)
Prev Close
$40.85
Open
$41.08
Day's High
$41.42
Day's Low
$40.83
Volume
1,600,316
Avg. Vol
1,074,474
52-wk High
$45.09
52-wk Low
$28.14

ZTS.N

Chart for ZTS.N

About

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs,... (more)

Overall

Beta: --
Market Cap (Mil.): $20,619.49
Shares Outstanding (Mil.): 501.32
Dividend: 0.07
Yield (%): 0.70

Financials

  ZTS.N Industry Sector
P/E (TTM): 36.70 36.60 37.24
EPS (TTM): 1.12 -- --
ROI: 10.83 18.95 18.21
ROE: 50.93 19.73 19.11
Search Stocks

Powerful antibiotic for cows often misused by farmers

NEW YORK/ATLANTA - It is one of the most potent antibiotics used by U.S. cattle and dairy farmers, the key component in the top-selling drug line of Zoetis, the world’s largest animal health company.

04 Dec 2014

BRIEF-Jinhe Biotechnology in sales contract with Zoetis

* Says signs sales contract for at least 301.05 million yuan(49.06 million US dollar) per year in 2015-2019 with Zoetis Inc's units in Belgium and Singapore

25 Nov 2014

Bayer explores possible sale of diabetes device unit: Bloomberg

- Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

25 Nov 2014

Bayer explores possible sale of diabetes device unit -Bloomberg

Nov 24 - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

25 Nov 2014

Losing Allergan deals blow to Valeant reputation

WINNIPEG/NEW YORK - The failure of Valeant Pharmaceuticals International Inc to buy Allergan Inc leaves it with nothing to show for a seven-month, bruising pursuit.

17 Nov 2014

Losing Allergan deals blow to Valeant reputation

WINNIPEG/NEW YORK Nov 17 - The failure of Valeant Pharmaceuticals International Inc to buy Allergan Inc leaves it with nothing to show for a seven-month, bruising pursuit.

17 Nov 2014

UPDATE 2-Allergan near buyout of up to $65 bln to escape Valeant, Ackman -source

(Adds source comments on potential pricing and Valeant moves)

17 Nov 2014

Zoetis adopts poison pill after Ackman picks up stake

Nov 14 - Zoetis Inc adopted a poison pill, three days after activist investor William Ackman's Pershing Square Capital Holdings revealed a stake in the animal health company.

15 Nov 2014

Ackman's Pershing Square takes 8.5 percent stake in Zoetis

By Narottam Medhora, Svea Herbst-Bayliss and Brendan Pierson | Video

13 Nov 2014

UPDATE 2-Ackman's Pershing Square takes 8.5 percent stake in Zoetis

BOSTON, Nov 11 - Activist hedge fund manager William Ackman's Pershing Square Capital Holdings said it had taken a 8.5 percent stake in animal health company Zoetis Inc for about $1.54 billion.

12 Nov 2014

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF91.75 +2.80
Merck & Co., Inc. (MRK.N) $57.63 --
Bayer AG (BAYGn.DE) €114.50 +2.40
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.26 +2.16
Eli Lilly and Co (LLY.N) $70.28 --

Earnings vs. Estimates

Search Stocks